Member Info for SteveV

Not much we didn't really know BUT very upbeat.
For me the best take aways were:
1 Sales and distributor network now WORLDWIDE.
2 Pipeline of products for Covid, Covid winding down, and post Covid
3 Molecular Diagnostics fastest growth area within a fast growing diagnostics sector.
4 The huge benefits of Promate(quicker, easier,no lab.) can be transferred to other Non-Covid tests
5 Near patient testing is a huge growth area. We already have the Q machines embedded.

We are basically a very successful, high revenue, high margin, company operating in a rapidly growing sector !!

I would expect the second half to be greater than the first half, therefore I think we will smash past £100m for 2021
(with no DHSC)............VERY solid indeed.

"...Novacyt will host a presentation and Q&A session, delivered by various members of the Executive Management Team. No new trading information will be disclosed during the presentation..."

We have had no news news prior and will get no new news during. THAT is why the sp is flat.

AND, we are only end of summer. What is Autumn/Winter going to be like..??

So the new guidelines for England regarding coming into contact with someone who has got Covid is now NOT to self isolate as per the previous guidelines. BUT, IF you have been vaccinated, get a PCR test.(instead of isolation)

NOTE: Not to get a LFT test, but a PCR test.
Business must be booming for NCYT..!

Let's face it the meeting is a PR job. What NCYT have been remarkably poor at to date.

GM has been particularly remiss at selling the business prospects. That has , combined with the DHSC debacle, probably
affected his decision to "retire"

New man, new direction, let's hope it's all up, instead of a roller coaster ride. Steady sustainable growth is what we want.

When volumes are low the price can often get eroded.

The mm's are trying to make a market. Reducing the price to tempt buying is all they got.

Things will pick up in Sept. after the hols are over. A lot of French people take ALL of August off.

"...Reliable tests in the emergency department, that come back within the hour, has been a game-changer and has made my life a million times easier," critical-care consultant Dr Annemarie Docherty, from the University of Edinburgh, said..."

Could it be those hospitals which had no access, or rejected, NCYT kit and tests were those that were least successful in controlling Covid in their hospital.

It does smack of a company going places. Lots of bright motivated people working in a booming business sector.

I wonder where NCYT are going to take the business next. Covid and post-Covid(if that ever happens !!!)
Lets not forget. They are usually ahead of the game !

I also wonder what is going on at IT-IS. Are they working on a killer new machine? A 15min. PCR test using Promate
would definitely " blow the doors off"

No body is going to want to do business with the DHSC at this rate.

Unless they pay cash up front and there is a NO return clause!!!!!

Does NCYT supply BioGrad? I can't remember

Avacta and ODX down 5% and 6% as I speak. Are they ever going to sell any product ?
NCYT do. LOTS. We are a very profitable business.

A lot has been said about the high price of testing by private companies.

The use of Promate (quicker, easier to use, doesn't require a lab) by private testing companies actually allows them to bring their prices DOWN because it makes them SO much more efficient.

Promate is a premium product. We could probably put OUR prices up and they would still buy it !!

I should think NCYT have had a very busy summer compared to last year by supplying a lot of the private testing companies.
Ticking over nicely. BUT does anyone really think that come autumn and winter we won't be busier than ever !!
Demand will be there. We got the products,we got the sales network. ....£££

I wouldn't be surprised if the DHSC came back for more product. !!

It's pretty easy pickings for MM's to target Pi's stop losses to fulfill the needs of the shorters' to cover their position.
That is when the sp is down trending. It WILL reverse eventually. The professional shorters' won't burn. They will have checked out and moved on.
It won't be long before we get a nice Bull run on NCYT. Looking forward to the day again when I make a lot of money before getting out of bed in the morning !!!!

It's pretty easy fo

I think NCYT have been quietly positioning themselves for a big push within the USA market.

I can see sales there going exponential in the coming months. I think Promate and Winterplex will be massive.

Hope the new CEO gets us listed on the US market. Followed shortly by a buyout from a large US Diagnostics company.
£54? .....Ah, we can dream!

Hey Glen, re: point 6 of my post. I came to that conclusion after reading some of Poidster's excellent posts over the last few days. Worth going back and reading if you missed.

We don't have any details of the Oxford Nanopore contract so can't really compare.

What we do know from the NCYT RNS is:
"...This first phase of the contract will involve the immediate deployment of 300 PCR instruments, related kits and support services with a minimum value of £150 million for the first 14 weeks. .."

So the DHSC AGREED to take a MINIMUM of £150m. That is what we delivered and invoiced. The DHSC chose not to extend the first phase or implement phase 2, BUT NCYT are saying that they fulfilled their part of the contract: "....the Company has taken legal advice and believes it has strong grounds to assert its contractual rights. ...."

For those that missed my post on Sat. regarding a possible timeline of events, here it is again.

1 DHSC buys a lot of the original PCR tests from NCYT, with a view to handing them out to NHS hospitals

2 A lot of the NHS hospitals rejected using them because they felt they were under resourced to use the tests(lack of staff and lab facilities). DHSC are left with surplus stock.(which has a shelf life)

3 Whilst this was occurring NCYT were already developing Promate to make the work flow quicker and easier, AND without the requirement for containment cabinets within labs.

4 Whilst this was occurring the Gov decides to decentralise procurement (which they are paying for) to the newer NHS framework which comes out of individual hospitals normal budgets (so the Gov don't have to shell out any more extra money)

5 The DHSC start the dispute with NCYT because they no longer want the old tests (which are aging and not as popular as Promate is), AND, if they can get a refund from NCYT for the central DHSC budget it saves a fortune as future costs come directly out of NHS budgets

6 NHS hospitals find they love Promate and are using whatever the can get. But eventually they run out. They could order more direct from NCYT from their own budgets BUT NCYT won't supply any more until the DHSC dispute is resolved.

Hopefully they are ALL working through a solution.!!!

I would have thought a simple way out and compromise would be for NCYT to say, IF the DHSC pay for all product ordered as per the contract they will replace any old product at cost price with Promate.
DHSC then can hand it out freely to NHS hospitals if they want ,OR, if they prefer, they could simply sell it to them until all stocks run out and then the NHS resumes ordering direct from NCYT who would be happy to supply.

I think a rough timeline of the DHSC/NCYT dispute/ scenario may be:

1 DHSC buys a lot of the original PCR tests from NCYT, with a view to handing them out to NHS hospitals

2 A lot of the NHS hospitals rejected using them because they felt they were under resourced to use the tests(lack of staff and lab facilities). DHSC are left with surplus stock.(which has a shelf life)

3 Whilst this was occurring NCYT were already developing Promate to make the work flow quicker and easier, AND without the requirement for containment cabinets within labs.

4 Whilst this was occurring the Gov decides to decentralise procurement (which they are paying for) to the newer NHS framework which comes out of individual hospitals normal budgets (so the Gov don't have to shell out any more extra money)

5 The DHSC start the dispute with NCYT because they no longer want the old tests (which are aging and not as popular as Promate is), AND, if they can get a refund from NCYT for the central DHSC budget it is saves a fortune as future costs come directly out of NHS budgets

6 NHS hospitals find they love Promate and are using whatever the can get. But eventually they run out. They could order more direct from NCYT from their own budgets BUT NCYT won't supply any more until the DHSC dispute is resolved.

Hopefully they are ALL working through a solution.!!!

I would have thought a simple way out and compromise would be for NCYT to say, IF the DHSC pay for all product ordered as per the contract they will replace any old product at cost price with Promate.
DHSC then can hand it out freely to NHS hospitals if they want ,OR, if they prefer, they could simply sell it to them until all stocks run out and then the NHS resumes ordering direct from NCYT who would be happy to supply.